To CANCER IMMUNITY Home Page

Figure 6

Recognition of peptide KELEGILLL by anti-LG2-C CTLs. 51Cr-labeled LG2-EBV cells were incubated for 30 minutes with various concentrations of the indicated peptides. CTL 220-1-14 was added at an effector to target ratio of 10:1. 51Cr release was measured after 4 hours.

 

Copyright © 2002 by B. Van den Eynde